Welcome to UK420

Register now to gain access to all of our features. Once registered and logged in, you will be able to contribute to this site by submitting your own content or replying to existing content. You'll be able to customize your profile, receive reputation points as a reward for submitting content, while also communicating with other members via your own private inbox, plus much more!

This message will be removed once you have signed in.

Dinafem Seeds 2016 Grow Diaries

Sign in to follow this  
Followers 0


76 topics in this forum

    • 245 replies
    • 125 replies
    • 18 replies
    • 63 replies
    • 17 replies
    • 46 replies
    • 271 replies
    • 167 replies
    • 95 replies
    • 192 replies
    • 59 replies
    • 34 replies
    • 339 replies
    • 7 replies
    • 198 replies
    • 280 replies
    • 39 replies
    • 20 replies
    • 329 replies
    • 52 replies
    • 14 replies
    • 33 replies
    • 45 replies
    • 96 replies
    • 97 replies
Sign in to follow this  
Followers 0

  • Posts

    • gonge
      Hey folks of UK420 . Was down in Edinburgh at weekend to get mucked and hit a show or 2. So after a few jugs of margarita and Mexican grub we headed to dynamic earth  where they were showing Gustav Holtz/ the planets  and also  pink floyds/ dark side o the moon in the planetarium    so after a priming ourselves with a fat one, in we go to see holtz planets.   Gets dark and before I know it, I’m soaring on my way through the solar system (it gets projected onto the dome ceiling) , classical music blasting in surround sound, was fekin excellent .  Back outside as got 40 mins till dark side.. another pint of innes  and gunns best craft lager ,another psychosis fat one then into see dark side..ticket guy gave us a sniff on way past ,said we were reeking and just smiled at us, absolute quality...  visuals where not authentic floyd stuff but loads o good kaleidoscope ,waves ,tunnels and generally mucky as fook stuff... not a word said during the whole album haha.. though a few grunts were heard when the room fell into a black hole   so it’s just to say at 12 sheets for a ticket each show, it was well worth it...  take it easy folks and stay monged.gonge.  . 
    • Jon Clobert
      Let's hope so guys. Thanks
    • Lancaster8
      The plant is allowed to dry out before it is watered again. I even have a professional moisture meter that gives me precise readings. Basically the plant gets watered every 3 days. The temperatures are perfect. The nutes vary enormously. I don't stick with any specific schedule currently, and this plant sometimes gets one product and sometimes others. I try to vary the diet!  - precisely to make sure it isn't short of anything.  This plant also had a surface dressing of chicken poo pellets in response to advice from someone else.
    • greensprout
          As adult-use and medical-marijuana policies become more commonplace, the canna-curious demographic is growing. Whether these naive consumers are interested in cannabis for its therapeutic or recreational benefits, many are not up for the gamble of smoking flower to see what happens. Rather, the new cannabis consumer is looking for an exact, consistent experience to reliably target either a particular medical ailment, or to bring about a specific, desired effect. And it turns out, these consistent, tailored experiences, as well as the technology used to procure them, comprise a company’s intellectual property — which can be transferred, legally, anywhere in the country. After all, we’re not talking about actual weed here, just its abstract scientific expression and methodology. Some companies are turning that into a growing business. Innovative research and development companies with clinical labs are experimenting with plant genetics and chromatography, using a process of trial and error to see how different cannabinoids and terpenes uniquely interact with the human body. Ebbu and LucidMood, for example, both out of Colorado, are working on ways to customize the user experience, even to customize the cannabis plant itself, in order to emphasize a particular set of compounds. “You can get something along the lines of a designer high,” says Tristan Watkins, chief science officer of LucidMood, which curates cannabinoid and terpene ratios to foster different moods for a line of vape pens (“party,” “bliss,” “relax,” “focus,” and “sleep” just to name a few). “We wanted to build additional formulations to help highlight or amplify the positive effect that people were looking for out of cannabis, while also mitigating the antithesis [of that effect],” he says.   RELATED Inside the Hunt for a Murderer Who Escaped from Prison 45 Years Ago Lawsuit: Mariah Carey’s Former Assistant Says She Was Peed On, Called a ‘Whore’   Manipulating the ratios of these compounds will be what brings cannabis to the mainstream, he says. “With this formulated cannabis you have a lot more control over how you feel and maintaining consistency in the product, regardless of what state it was created in.” And that curated cannabis product will be the same six months later, or whenever you next try it. “It removes a lot of concern and perceived risk for the consumer,” Watkins adds. To draft a formulation, scientists must first deconstruct the cannabis plant down to its individual compounds. Then, they can study the effects of those compounds, in isolation. To understand, for instance, the extent to which the terpene linalool causes drowsiness, scientists would first look at how a particular ratio of THC and CBD alone impacts energy, and then what happens when a certain amount of linalool is added to that ratio. “We build up a step-by-step process until we find that our formulation was efficacious,” Watkins explains. While THC and CBD are the most well-known cannabinoids, the cannabis plant contains dozens of active compounds — meaning that lesser known cannabinoids like CBN or CNG, for instance, as well as various terpenes, have yet to grab the spotlight. However, by isolating these compounds, scientists can better understand how they work and how to use them in context. “There’s no way to make a true mainstream [product] unless you can deliver on the concept of trust,” says Jon Cooper, founder and former CEO of Ebbu, now vice president of business development for Canopy, which acquired Ebbu for $4 million in October. “When we looked at this plant, we quickly started realizing that this thing is chemical chaos.” That’s what led Cooper and his colleagues to break down the cannabis plant and put those isolated compounds back together into specific combinations for a consistent experience. Founded in 2013, Ebbu built a discovery lab for cannabinoids. There, scientists started to grow live human receptors to understand, in real time, how they would interact with those compound isolates.   However, beyond constructing novel cannabinoid/terpene combinations, Ebbu has gone one step further to “genetically edit” the plant so that it produces greater or lesser volumes of specific compounds. In doing so, scientists can create larger amounts of those compounds in a way that makes them commercially viable, Cooper explains. (Genetic editing, he points out, is different from genetic modification in that the latter introduces DNA, chromosomes, or some other foreign entity, such as a pesticide, into the plant, while the former works with the material that’s already, inherently there.) “That’s something we can replicate worldwide,” he says.”The goal here was twofold: How do we create the best, most enjoyable recreational products, but how do we utilize these cannabinoids to create the most efficaciou medicine that I truly believe has the opportunity for changing the lives for hundreds of millions of people?” But moreover, he says, this form of cannabis medicine has the added bonus of not feeling like actual medication. “Wouldn’t it be great if they could drink a tea, versus popping a pill?” Cooper says. “In the next ten years, smokeable flower form will be less than 10 percent of what’s consumed in the marketplace — people won’t think of [cannabis] as a stoner thing anymore.” What’s more, by conceiving of cannabis via scientific equations or as novel (read: edited) plant varieties, companies can license their IP anywhere in the world — legally. Those executing cannabis R&D have the option to retain their IP as trade secret, or to partner with a cultivation company in any state in order to share their own proprietary cannabinoid/terpene ratios or technology — like that behind Ebbu’s genetic editing technique — to co-create weed-based, designer products. “Under patent law, there’s no prohibition on patenting cannabis related technology,” says Alison Malsbury, a San Francisco-based intellectual property attorney with cannabis law firm Harris Bricken. “For that reason, there’s no problem with patenting formulations of cannabis compounds so long as they meet other requirements for patentability.”   To get a patent, the invention must be novel, as well as non-obvious, and cannot already exist in nature. A wild strain of cannabis, for instance, could not be patented because the genetics weren’t manipulated or human-bred. But for proprietary blends or genetic editing technology, the incentive to patent would be to gain a limited monopoly (which lasts only a couple decades), so that the party seeking the patent is the only one who can make or sell the product, or license other people to do so. “The thing that operators need to be aware of is if they transfer ownership of the patented technology to another company, how that company made use of that technology would be dictated by state law,” says Malsbury. “You can patent cannabis-related technology all day long and not violate federal law, but where federal law comes into play is where you are actually using that patented technology.” In California, only license-holders can participate (and collaborate with other license-holders) in the state’s regulated system. Another thing to beware of are patent trolls, she adds, companies that buy up patented technology in a variety of industries, but never use that technology — rather, they just use their patent rights to prevent other people from using that technology and to extort licensing fees. Even so, these artificial preparations of cannabis compounds are different, namely because whoever made the artifice is likely the sole party to come up with that specific combination. “Formulations are going to be one of the best routes to actually obtaining patent protection and that’s what’s appealing to pharmaceutical companies,” Malsbury says. “As we see them starting to take interest in cannabis, I think formulations will be one of the means by which they stake their claims in the market.” There’s also something called a method patent, which makes proprietary the way something is made (assuming it’s a new method). “We’re seeing more people patenting the strains and formulations, as well as the methods of making these formulations,” says IP attorney John Mansfield, owner of Portland, Oregon’s Mansfield Law. With plenty of controversy around patent infringement lawsuits, Mansfield asks “whether we should be patenting cannabis at all.”